Biopharma Analysis

Naldemedine Approved in China for Opioid-Induced Constipation: A New Option for Cancer Supportive Care

NMPA · Opioid-Induced Constipation · 9 min

Viridian Partners with WuXi Bio for Eye Drug Supply Amid FDA Decision

FDA · 4 min

Gilead's $140M Deal with Yuhan: Implications for Pharma

2 min

Roche's Licensing Deal for Xofluza: Implications and Insights

3 min